# A Multi-Institutional Phase II Study of Cyclophosphamide, Paclitaxel, Cisplatin With G-CSF for Patients With Newly Diagnosed Advanced Stage Ovarian Cancer

> **NCT00001426** · PHASE2 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 66 (actual)

## Conditions studied

- Ovarian Neoplasm

## Interventions

- **DRUG:** Cyclophosphamide
- **DRUG:** Paclitaxel
- **DRUG:** Cisplatin
- **DRUG:** G-CSF

## Key facts

- **NCT ID:** NCT00001426
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1995-02-03
- **Primary completion:** 2007-10-15
- **Final completion:** 2013-11-07
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2018-04-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00001426

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00001426, "A Multi-Institutional Phase II Study of Cyclophosphamide, Paclitaxel, Cisplatin With G-CSF for Patients With Newly Diagnosed Advanced Stage Ovarian Cancer". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT00001426. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*